Skip to Content

User Reviews for Halaven

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Reviews for Halaven to treat Breast Cancer

No reviews have yet been submitted. Be the first to review this drug.

Learn more about Breast Cancer

Micromedex® Care Notes

Breast Cancer In Women

Symptom checker

Breast Lumps

Symptoms and treatments

Breast Cancer

Drugs.com Health Center

Mayo Clinic Reference

Breast cancer

More about Halaven (eribulin)

Consumer resources

Professional resources

Related treatment guides

Drug Status

Rx

Availability Prescription only

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

Manufacturer

Eisai Inc.

Drug Class

Mitotic inhibitors

Related Drugs

Breast Cancer, Metastatic Arimidex, Femara, Xeloda, Herceptin, Ibrance, Faslodex, Kisqali, Lynparza, More...

Breast Cancer Arimidex, Femara, Xeloda, Herceptin, Ibrance, Afinitor, Faslodex, Kisqali, More...

Liposarcoma palbociclib, eribulin, More...

Help and Support

Looking for answers? Ask a question or go join the Halaven support group to connect with others who have similar interests.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated June 1st, 2018), Cerner Multum™ (updated June 5th, 2018), Wolters Kluwer™ (updated June 4th, 2018) and others. To view content sources and attributions, please refer to our editorial policy.